Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia

BACKGROUND Genes involved in phosphoinositide (PI) lipid metabolism are excellent candidates to consider in the pathogenesis of bipolar disorder (BD) and schizophrenia (SZ). One is PIK3C3, a member of the phosphatidylinositide 3-kinase family that maps closely to markers on 18q linked to both BD and SZ in a few studies. METHODS The promoter region of PIK3C3 was analyzed for mutations by single-strand conformation polymorphism analysis and sequencing. A case-control association study was conducted to determine the distribution of variant alleles in unrelated patients from three cohorts. Electromobility gel shift assays (EMSA) were performed to assess the functional significance of variants. RESULTS Two polymorphisms in complete linked disequilibrium with each other were identified, -432C- > T and a "C" insert at position -86. The -432T allele occurs within an octamer containing an ATTT motif resembling members of the POU family of transcription factors. In each population analyzed, an increase in -432T was found in patients. EMSAs showed that a -432T containing oligonucleotide binds to brain proteins that do not recognize -432C. CONCLUSIONS A promoter mutation in a PI regulator affecting the binding of a POU-type transcription factor may be involved in BD and SZ in a subset of patients.

[1]  P. Camilli,et al.  A presynaptic inositol-5-phosphatase , 1996, Nature.

[2]  W. Herr,et al.  The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. , 1995, Genes & development.

[3]  J. Kelsoe,et al.  Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder , 2003, Molecular Psychiatry.

[4]  Kari Stefansson,et al.  Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. , 2003, American journal of human genetics.

[5]  E. Robins,et al.  Research diagnostic criteria. , 1975, Psychopharmacology bulletin.

[6]  T. Crow,et al.  A genome-wide search for schizophrenia susceptibility genes. , 1998, American journal of medical genetics.

[7]  J. Nurnberger,et al.  Chromosome 6 workshop report. , 1999, American journal of medical genetics.

[8]  Henrik Ewald,et al.  Search for a shared segment on chromosome 10q26 in patients with bipolar affective disorder or schizophrenia from the Faroe Islands. , 2002, American journal of medical genetics.

[9]  D. Latchman,et al.  POU family transcription factors in the nervous system , 1999, Journal of cellular physiology.

[10]  L. Pirola,et al.  Structure and function of phosphoinositide 3-kinases. , 1998, Biochimica et biophysica acta.

[11]  P. Camilli,et al.  PIP Kinase Iγ Is the Major PI(4,5)P2 Synthesizing Enzyme at the Synapse , 2001, Neuron.

[12]  John P. Rice,et al.  Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigrees. , 2000, American journal of medical genetics.

[13]  P. De Camilli,et al.  Phosphoinositides in membrane traffic at the synapse. , 2001, Journal of cell science.

[14]  Lei Zhang,et al.  Cyclin-dependent Kinase-5 Is Involved in Neuregulin-dependent Activation of Phosphatidylinositol 3-Kinase and Akt Activity Mediating Neuronal Survival* , 2003, Journal of Biological Chemistry.

[15]  T. Matise,et al.  Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. , 1998, American journal of medical genetics.

[16]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[17]  C. Dion,et al.  A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes , 2001, Molecular Psychiatry.

[18]  F. McMahon,et al.  Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 1, 6, 8, 10, and 12. , 1997, American journal of medical genetics.

[19]  Graham L. Collingridge,et al.  Phosphatidylinositol 3 kinase regulates synapse specificity of hippocampal long-term depression , 2002, Nature Neuroscience.

[20]  E. Nestler,et al.  Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[21]  R. Lenox,et al.  Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks , 2003, Molecular Psychiatry.

[22]  G. Moore,et al.  Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers , 2001, British Journal of Psychiatry.

[23]  J. Kelsoe,et al.  Linkage studies suggest a possible locus for bipolar disorder near the velo-cardio-facial syndrome region on chromosome 22. , 1997, American journal of medical genetics.

[24]  E. Robins,et al.  Research diagnostic criteria: rationale and reliability. , 1978, Archives of general psychiatry.

[25]  R. MacQuarrie,et al.  Lithium Effects on Inositol Phospholipids and Inositol Phosphates: Evaluation of an In Vivo Model for Assessing Polyphosphoinositide Turnover in Brain , 1992, Journal of neurochemistry.

[26]  M. Rosenfeld,et al.  A two-base change in a POU factor-binding site switches pituitary-specific to lymphoid-specific gene expression. , 1990, Genes & development.

[27]  M. Rietschel,et al.  Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. , 1998, American journal of medical genetics.

[28]  M. Chao,et al.  Differential association of phosphatidylinositol-5-phosphate 4-kinase with the EGF/ErbB family of receptors. , 1999, Cellular signalling.

[29]  N. Freimer,et al.  Genome screening for linkage disequilibrium in a Costa Rican sample of patients with bipolar-I disorder: a follow-up study on chromosome 18. , 2001, American journal of medical genetics.

[30]  Feng Yang,et al.  PI-3 kinase and IP3 are both necessary and sufficient to mediate NT3-induced synaptic potentiation , 2001, Nature Neuroscience.

[31]  G. Prestwich,et al.  A Pleckstrin Homology Domain Specific for Phosphatidylinositol 4,5-Bisphosphate (PtdIns-4,5-P2) and Fused to Green Fluorescent Protein Identifies Plasma Membrane PtdIns-4,5-P2 as Being Important in Exocytosis* , 2000, Journal of Biological Chemistry.

[32]  J. Dixon,et al.  The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Ciesielski,et al.  Evaluation of Systemically Administered Radiolabeled Epidermal growth Factor as a Brain Tumor Targeting Agent , 2001, Journal of Neuro-Oncology.

[34]  P. Holmans,et al.  Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. , 2000, American journal of human genetics.

[35]  L R Goldin,et al.  A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  B. Luisi,et al.  The virtuoso of versatility: POU proteins that flex to fit. , 2000, Journal of molecular biology.

[37]  H. N. Freeman,et al.  Phosphorylation of a Synaptic Vesicle-associated Protein by an Inositol Hexakisphosphate-regulated Protein Kinase* , 2001, The Journal of Biological Chemistry.

[38]  Y. Nishizuka Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.

[39]  J. Brady,et al.  The class III POU factor Brn-4 interacts with other class III POU factors and the heterogeneous nuclear ribonucleoprotein U. , 1997, Brain research. Molecular brain research.

[40]  F. Zhao,et al.  Involvement of Oct-1 in transcriptional regulation of beta-casein gene expression in mouse mammary gland. , 2002, Biochimica et biophysica acta.

[41]  M. Gladis,et al.  Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample. , 2000, American journal of medical genetics.

[42]  J. Nurnberger,et al.  Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Klein,et al.  Mutation analysis of SYNJ1: a possible candidate gene for chromosome 21q22-linked bipolar disorder , 2001, Molecular Psychiatry.

[44]  M. Boehnke,et al.  Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample. , 2001, American journal of medical genetics.

[45]  W. Honer,et al.  Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. , 2000, Science.

[46]  D. Melton,et al.  A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[47]  L. Siever,et al.  Genome scan of schizophrenia , 1998 .

[48]  Michael J. Berridge,et al.  Inositol phosphates and cell signalling , 1989, Nature.

[49]  J S Sinsheimer,et al.  Chromosome 1 loci in Finnish schizophrenia families. , 2001, Human molecular genetics.

[50]  J. Williamson,et al.  Formation and metabolism of inositol 1,3,4,5-tetrakisphosphate in liver. , 1986, The Journal of biological chemistry.

[51]  O. Mors,et al.  Susceptibility loci for bipolar affective disorder on chromosome 18? A review and a study of Danish families , 1997, Psychiatric genetics.

[52]  C. Beasley,et al.  Expression of Oct-6, a POU III domain transcription factor, in schizophrenia. , 2002, The American journal of psychiatry.

[53]  H. Lachman,et al.  Polymorphism Screening of PIP5K2A: A Candidate Gene for Chromosome 10p‐Linked Psychiatric Disorders , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[54]  Richard A. Firtel,et al.  Leading the way: directional sensing through phosphatidylinositol 3-kinase and other signaling pathways , 2003, Journal of Cell Science.

[55]  D. Eberhard,et al.  Evidence that the inositol phospholipids are necessary for exocytosis. Loss of inositol phospholipids and inhibition of secretion in permeabilized cells caused by a bacterial phospholipase C and removal of ATP. , 1990, The Biochemical journal.

[56]  Y. Okubo,et al.  Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples , 2001, Molecular Psychiatry.

[57]  R. Jope,et al.  Mood stabilizers, glycogen synthase kinase-3β and cell survival , 2002, Molecular Psychiatry.

[58]  A. Toker,et al.  Signalling through the lipid products of phosphoinositide-3-OH kinase , 1997, Nature.

[59]  W. Berrettini,et al.  Are schizophrenic and bipolar disorders related? A review of family and molecular studies , 2000, Biological Psychiatry.

[60]  T. Matise,et al.  Suggestive linkage of chromosome 10p to schizophrenia is not due to transmission ratio distortion. , 1999, American journal of medical genetics.

[61]  H. Kobayashi,et al.  Roles of synaptotagmin C2 domains in neurotransmitter secretion and inositol high-polyphosphate binding at mammalian cholinergic synapses. , 1997, Neuroscience.

[62]  M. Caron,et al.  Agonist-dependent Recruitment of Phosphoinositide 3-Kinase to the Membrane by β-Adrenergic Receptor Kinase 1 , 2001, The Journal of Biological Chemistry.

[63]  P. Schofield,et al.  A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19 , 2002, Molecular Psychiatry.

[64]  Jurg Ott,et al.  A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3 , 1994, Nature Genetics.

[65]  N. Schork,et al.  A genome-wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the Old Order Amish. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[66]  S. García-Silva,et al.  An Element in the Region Responsible for Premature Termination of Transcription Mediates Repression of c-myc Gene Expression by Thyroid Hormone in Neuroblastoma Cells* , 2000, The Journal of Biological Chemistry.

[67]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[68]  M. Caron,et al.  Phosphoinositide 3-kinase regulates β2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/β-arrestin complex , 2002, The Journal of cell biology.

[69]  P. Sharp,et al.  A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes , 1986, Nature.

[70]  J. Endicott,et al.  A diagnostic interview: the schedule for affective disorders and schizophrenia. , 1978, Archives of general psychiatry.

[71]  P. Gean,et al.  A Role for the PI-3 Kinase Signaling Pathway in Fear Conditioning and Synaptic Plasticity in the Amygdala , 2001, Neuron.

[72]  R. Straub,et al.  A schizophrenia locus may be located in region 10p15-p11. , 1998, American journal of medical genetics.

[73]  R. Jope,et al.  Effects of chronic lithium treatment on protein kinase c and cyclic AMP-dependent protein phosphorylation , 1991, Biological Psychiatry.

[74]  W. Sherman,et al.  The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. , 1980, The Journal of biological chemistry.